Search Results
Results found for "Structure Therapeutics"
- Dr. Arun Shukla | Dr. GPCR Ecosystem
Arun first started working on GPCRs and their structural characterization at the Max Planck Institute
- Celtarys Research | Dr. GPCR Ecosystem
Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
that MRAP2 regulates the signaling of multiple G protein-coupled receptors (GPCRs) through different structural C-terminal tail is not a docking space for the arrestins, but rather a necessary modification leading to a structural
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Specialized Training — Build GPCR Expertise Within Your Team Strengthen your team’s GPCR knowledge with structured University Team Membership Biotech Growth Workshops — Scale With Strategy Replace trial-and-error with structured
- Dr. John Janetzko | Dr. GPCR Ecosystem
Daniel Kahne and Suzanne Walker studying the structure and function of the essential human enzyme, O-GlcNAc Over the course of my graduate work, I gained experience with structural mass spectrometry and protein position after the recording stops. • John will prioritize getting feedback from people outside his lab to structure
- Dr. Patrick Sexton | Dr. GPCR Ecosystem
More recently, his team has been at the forefront of the application of cryo-EM to elucidate of the structure
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
His doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic
- Plenary Lecture | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Our fourth main research aspect is ligand coding mechanisms and structural aided drug discovery of GPCR
- Inês Pinheiro, Monserrat Avila Zozaya & Yamina Berchiche | Dr. GPCR Ecosystem
She developed expertise over the past two decades studying structure/function relationships of GPCRs
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
Keith Moffat, he studied the structural mechanisms of bacterial photoreceptors using time-resolved Laue
- University Pricing | Dr. GPCR Ecosystem
DrGPCR helps you understand and apply that knowledge — through structured training, expert context, and 🧩 Step 1: Fill Out the Instructor Form 🧱 Step 2: Plan Your Course Structure 📝 Step 3: Prepare Your
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April biotechs public Aikium's AI-Driven mRNA Engine Looks to Address Undruggable Disordered Proteins Tectonic Therapeutic - 21, 2025 | 2nd GPCR signaling and drug discovery Symposium & Workshop NEW April 2 - 3, 2025 | New therapeutic Pharmacology 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Structural PhD Position GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Richard Premont | Dr. GPCR Ecosystem
In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
She identified the structural determinant controlling biased signaling of melatonin type 2 receptors
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
mechano-activation- activation scenario that forms the basis for her current projects that focus on the structural
- VC Insights | Dr. GPCR Ecosystem
I bring structure, decision frameworks, and momentum so your team stays on track.
- CRO Advisory | Dr. GPCR Ecosystem
I help CRO teams bring structure to collaboration—so your data gets acted on, not overlooked.
- What do mission-driven teams and world-class science have in common? ✅ Integrity ✅ Systems that last ✅ The right people In this episode, Joe & Chuck from Company Launch Partners share what it means to build something that endures. 🎧 Catch the full episode: Ep 165 with Chuck DeWeese & Joe St. Germain #gpcr #DrGPCR #ScienceStartup | Dr. GPCR Ecosystem
It is structural. When complexity grows faster than strategy, biotech companies drift.
- Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem
a Ph.D. degree in 2003 with a particular interest in the cardiovascular system by investigating the structure
- Check out the new optical BRET-based biosensor, Gαi bONE-GO! In neuronal cell lines, the use of Gαi bONE-GO revealed that several natural opioid neuropeptides act as partial agonists, contrary to their previous characterization as full agonists. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️https://buff.ly/e6gAlBv #gpcr#drgpcr | Dr. GPCR Ecosystem
It is structural. When complexity grows faster than strategy, biotech companies drift.
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
The program will include also world-class and diverse GPCR scientists working in the arenas of structure
- Our History | Dr. GPCR Ecosystem
Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
By integrating advanced tools and translational biology, his work directly informs therapeutic strategies
- GPCR CRO Bank | Dr. GPCR Ecosystem
ecosystem Support inbound inquiries from teams actively evaluating CROs, platforms, or tools Present clear, structured
- Started in medicinal chemistry. Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. A thesis project, a mentor’s advice, and a leap during the pandemic changed everything. Now she’s leading Celtarys, building custom fluorescent probes, and partnering with Dr. GPCR to support assay development worldwide. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen now: https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRcommunity #DrGPCR #FluorescentLigands #GPCRdrugDiscovery #ScientificLeadership #BiotechInnovation | Dr. GPCR Ecosystem
It is structural. When complexity grows faster than strategy, biotech companies drift.
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
It is structural. When complexity grows faster than strategy, biotech companies drift.


















